LYNCH DANIEL (CIK 1177082) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-02). Recent activity: Sell SWTX (93,004 shares), Buy SWTX (10,060 shares), Sell SWTX (44,018 shares), Sell SWTX (3,582 shares), Sell SWTX (400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 93,004 | $0 |
| 2025-05-15 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Buy | 10,060 | $0 |
| 2025-02-24 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 44,018 | $2.6M |
| 2025-02-24 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 3,582 | $219,362 |
| 2025-02-19 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 400 | $24,000 |
| 2025-02-12 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 69,766 | $3.7M |
| 2025-02-12 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 39,634 | $2.2M |
| 2025-02-12 | SpringWorks Therapeutics, Inc. (SWTX) | Director | Sell | 65,600 | $3.6M |
Source: SEC Form 4 filings · as of 2025-07-02